(April 26, 2024, 10:15 AM EDT) -- CAMDEN, N.J. — A federal magistrate judge in New Jersey granted preliminary approval to a $97 million settlement in a case brought against a pharmaceutical company and certain of its executives by shareholders accusing the company of artificially inflating stock value to stave off a buyout....